Cite
Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development
MLA
Egbert F. Smit, et al. Optimising Translational Oncology in Clinical Practice: Strategies to Accelerate Progress in Drug Development. Jan. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d983e9861558ae014805633a861358e7&authtype=sso&custid=ns315887.
APA
Egbert F. Smit, Sabine Tejpar, Martine Piccart, Stephen P. Finn, Dirk De Ruysscher, E. Van Cutsem, Michel Ducreux, Rolf A. Stahel, Jan Bogaerts, Christos Sotiriou, Solange Peters, Fortunato Ciardiello, Josep Tabernero, P. Dubsky, & Pierre Laurent-Puig. (2015). Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development.
Chicago
Egbert F. Smit, Sabine Tejpar, Martine Piccart, Stephen P. Finn, Dirk De Ruysscher, E. Van Cutsem, Michel Ducreux, et al. 2015. “Optimising Translational Oncology in Clinical Practice: Strategies to Accelerate Progress in Drug Development,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d983e9861558ae014805633a861358e7&authtype=sso&custid=ns315887.